Use of Biosynthetic Controls as Performance Standards for Next-Generation Sequencing Assays of Somatic Tumors: A Multilaboratory Study.
De Abreu FB, Peterson JD, Deharvengt SJ, Daber R, Sarsani VK, Spotlow V, Harrington RD, Lih CJ, Williams PM, Bouk CH, Konigshofer Y, Huang C, Anekella B, Davis L, Garlick RK, Ferreira-Gonzalez A, Dumur CI, Fernandes H, Haralampu S, Tsongalis GJ.
De Abreu FB, et al.
J Appl Lab Med. 2017 Sep 1;2(2):138-149. doi: 10.1373/jalm.2017.023085.
J Appl Lab Med. 2017.
PMID: 32630970